Carbamazepine Tablets Suppliers & Bulk Manufacturers
Available Forms: Extended-release (XR) tablets
Available Strengths: 200 mg, 300 mg, 400 mg
Reference Brands: Tegretol XR
Category: Drugs Using Osmotic Pump Systems
Tegretol XR® (carbamazepine) works by inhibiting voltage-gated sodium channels in nerve cells, stabilizing electrical activity. It effectively treats epilepsy, neuralgia, and bipolar disorder. Benefits include reduced seizure frequency, pain relief, mood stabilization, improved quality of life, and better patient adherence with sustained-release dosing. Carbamazepine tablets is available in Extended-release (XR) tablets and strengths such as 200 mg, 300 mg, 400 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Carbamazepine tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Carbamazepine tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Tegretol XR® (carbamazepine) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality aligned with GMP and MDR standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Prazosin Hcl Tablets
Strength:
1 mg, 2 mg, 5 mg,10 mg
Form: Extended-release (ER) tablets
Reference Brands: Alpress LP
View DetailsDoxazosin Mesylate Capsules
Strength:
4 mg, 8 mg, and 12 mg
Form: Extended-release (ER) capsules
Reference Brands: Cardura XL
View DetailsVerapamil Hcl Tablets
Strength:
240 mg once daily
Form: Sustained-release tablets
Reference Brands: Covera-HS®
View DetailsMethylphenidate Hcl Tablets
Strength:
18 mg, 27 mg, 36 mg, 54 mg ER tablets
Form: Extended-release (ER) tablets
Reference Brands: Concerta
View DetailsQuick Response Guaranteed | Verified Suppliers